University of Chile Scientists’ Study Indicates Sinovac’s Vaccine Elicits More Transmissible & Potent Variant called Lambda

University of Chile Scientists' Study Indicates Sinovac’s Vaccine Elicits More Transmissible & Potent Variant called Lambada

The variant of concern (VoC) called C.37 or the “Lambda variant,” was probably first identified in Peru about one year ago, which fuels growing concern that mutations could overpower existing COVID-19 vaccines. The World Health Organization (WHO) reports that this mutant variant could not only boost transmissibility but also strengthen the pathogen’s resistance to vaccine-elicited neutralizing antibodies. It is not known yet what the impact of this variant will be, reports a new study, but the investigators do speculate that there could be a result of this viral adaptation to the CoronaVac vaccine, produced by the Chinese corporation Sinovac. That’s right: if this study is correct, the CoronaVac vaccine could be correlated to a mutation, one that’s led to a more transmissible and potent mutant. The authors suggest mass vaccination programs conducted directly in SARS-CoV-2 hotspots should be coupled with "strict genomic surveillance."

Led by corresponding authors Ricardo Soto-Rifo and Fernando Valiente-Echeverría Laboratorio de Virología Molecular y Celular, Programa de Virología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile, the ...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee